If two strips contain the same active salt in the same strength, why can one cost several times more? The short answer: branding, distribution, and perception — not a different molecule.
This article explains what “generic” means in the Indian regulatory context, what bioequivalence guarantees, and how to talk about alternatives without compromising care.
What “Generic” Means in India
A generic medicine contains the same active pharmaceutical ingredient (API), in the same strength and dosage form, as a reference product. It must meet quality, safety, and efficacy standards overseen through the CDSCO / state licensing framework.
Generics are not “duplicate street copies.” Licensed generics are manufactured under approved facilities and tested against pharmacopoeial standards.
Bioequivalence in Plain Language
For many oral solid dosages, regulators expect generics to demonstrate bioequivalence — meaning the active salt reaches the bloodstream in a comparable rate and extent to the reference product, within accepted statistical limits.
That is why, for common chronic therapies (many antihypertensives, antidiabetics, antibiotics), salt-matched generics are clinically interchangeable for most patients when a doctor agrees.
Where Brand Premiums Come From
- Sales force and medical marketing
- Brand recall among patients and chemists
- Packaging and perceived “trust signalling”
- Distribution margins across trade channels
None of these automatically equal superior therapeutic molecules. The salt does the clinical work; the brand wraps it.
When Brands May Still Be Preferred
- Your doctor has documented intolerance or inconsistent response after a prior switch
- The medicine has a narrow therapeutic index
- Device/inhaler technique is brand-specific
- Supply reliability of a particular manufacturer matters for continuous therapy
A Practical Comparison Framework
| Check | Why it matters |
|---|---|
| Salt + strength + form | Must match the prescribed therapy |
| Licensed manufacturer | Avoid unregulated / suspicious packs |
| MRP and strip count | Compare cost per equivalent dose |
| Prior clinical response | Stability on current brand may outweigh savings |
| Doctor approval | Especially for chronic / specialist medicines |
Questions Worth Asking in the Clinic
- “Is a quality generic acceptable for this salt?”
- “Are there any reasons I should stay on this exact brand?”
- “If I switch, what should I monitor for two weeks?”
Inactive Ingredients: Why Two Packs Can Feel Different
Even with the same salt, fillers, coatings, and colourants can differ. A minority of patients notice taste, stomach tolerance, or allergy to a specific excipient. If that happens after a switch, report it and consider returning to the prior formulation with clinician guidance.
Private Generic vs Public Generic Channels
India has both competitive private generics and public affordable channels (including Jan Aushadhi for many molecules). “Generic” is a category, not a single quality tier. Evaluate the specific manufacturer and pack in front of you.
How SearchMyMed Fits In
Search the salt name to see composition clarity and brand landscape. Use the directory as a preparation tool for clinician conversations — not as a substitute for medical advice.
Bottom line: Brand vs generic is mostly about packaging and price once salt, strength, and clinical suitability align. Ask once; save for years on chronic therapy.
Frequently Asked Questions
What are "Lower-Cost Alternatives" and can I switch medicines safely?
Lower-cost alternatives are bioequivalent medicine formulations manufactured by different pharma brands that contain the exact same active pharmaceutical ingredient (API), safety, and strength profile. While our indexing filters help identify cost-effective substitutes, you should always consult your treating medical professional before altering an active prescription plan.
Why do two medicines with the exact same active salt vary so dramatically in price?
Pharmaceutical pricing disparities usually boil down to commercial overhead parameters rather than clinical formulation differences. Brand-name medicines backed by massive marketing systems, extensive distribution networks, or international patent logistics are marked at higher retail price points, whereas high-quality, bioequivalent generic alternatives skip these promotional markups to pass direct cost reductions onto patients.
